Latest News

Q4 2023 Watch: Bipartisan PEPFAR reauthorization push; ADAP coverage and Medicaid updates tracked.

Research proves alcohol doesn't reduce DAA efficacy for HCV, yet payers continue restricting treatment.

OIG report: 27% of Medicaid HIV enrollees lack evidence of critical services; state disparities exposed.

Medicaid unwinding: 74% of 5.5M disenrollments due to procedural errors, not ineligibility.

Q3 2023 Watch: HIV disparities coverage; debt ceiling crisis impacts; Medicaid disenrollment trends tracked.

Mid-year policy update covering Medicaid unwinding, ACA preventive care, and public health funding.

Q2 2023 Watch: Braidwood decision impacts PrEP coverage; ADAP coverage analysis and Medicaid program updates.

HCV Medicaid Access dashboard 2023 update: progress in eliminating treatment restrictions by state.

Q1 2023 Watch: Tennessee rejecting federal HIV funding; updates on ADAPs, Medicaid, veterans care, and harm reduction.

Tennessee rejects $8.3M in federal HIV prevention funding, threatening surveillance and care programs.

Preview of 2023 federal regulatory priorities: Section 1557, IRA implementation, and prior authorization reform.

2023 outlook: CVS PBM discrimination lawsuit, Medicaid enforcement, and state-sponsored discrimination threats.

Q4 2022 Watch: HHS renewed opioid emergency; CANN launched monkeypox project; HEPLISAV-B hepatitis B vaccine covered.

Only 35% of privately insured and 23% of Medicaid patients initiate HCV treatment due to payer barriers.

Innovative HIV medications available but inaccessible: payer barriers block Cabenuva and Apretude access.

Medicaid sobriety restrictions on HCV treatment contradict harm reduction and elimination goals.

CANN announces 2022 organizational changes including rebranding and launching the 340B Action Center.

Payers restrict HCV treatment through utilization management; patient assistance programs fill the critical gap.

Analyzes CMS marketplace rule changes and Medicaid expansion risks as pandemic emergency declarations end.

Analyzes Biden health policy priorities including drug pricing reform and Medicare expansion.